Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-10-23 00:00:00 ET · period of report 2024-10-21 · accession 0001140361-24-044060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-23 | 2024-10-21 | ROIV | Epperly Melissa B, | Dir | A - Grant | $0.00 | +1,613 | 38.0K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-10-21 | A | A | 1,613 | $0.00 | 38,037 | D | — | — | (F1) Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |